The Pharmacy Times® Asthma Resource Center is a comprehensive resource for clinical news and expert insights on issues related to the treatment of the chronic lung disease, in which the airways narrow and swell.
April 16th 2024
The authors note that additional research needs to be conducted to confirm whether the findings are consistent in adult patients.
FDA Approves Fluticasone Furoate, Umeclidinium, Vilanterol for Treatment of Asthma
September 14th 2020The triple combination therapy is the first single inhaler triple therapy approved for both asthma and COPD and is the only single inhaler triple therapy available as a once-daily inhalation.
Read More
Data Suggest Asthma Associated With Longer Time on Ventilators for Younger COVID-19 Patients
May 20th 2020Patients with COVID-19 between the ages of 20 and 59 years who also had asthma needed a ventilator to assist with breathing for 5 days more on average than non-asthmatic patients with COVID-19, according to a press release.
Read More
New Study Seeks to Determine Incidence Rate of COVID-19 in Children
May 5th 2020A study to help determine the incidence rate of the coronavirus disease 2019 (COVID-19) in children and their family members has begun enrolling participants in the United States, according to the National Institutes of Health (NIH).
Read More
Study: High Levels of Iron in Lungs Linked to Increased Asthma Severity
March 24th 2020The study, which includes data from asthma patient samples and mouse models, is the first to definitively show a relationship between iron build-up in the lung cells and tissues and the severity of asthma, according to the researchers.
Read More
Study Finds Bidirectional Relationship Between Asthma and Migraines
March 9th 2020In the first report of its kind, a recent study compiled Korean Health Insurance Review and Assessment Service data from 2002 to 2013 to evaluate a bidirectional association between asthma and migraines in Korean adults.
Read More
Study Supports Added Use of Tiotropium Bromide for Asthma
February 16th 2020Results from a new retrospective analysis have shown that patients prescribed tiotropium bromide (Spiriva Respimat) inhalation spray 1.25 mcg experienced fewer asthma-related exacerbations when the treatment was added to a combination inhaled corticosteroid and long-acting beta2 agonist (ICS + LABA), compared with patients who received an increased dose of ICS + LABA.
Read More
Benralizumab Approved by FDA as Self-Administered Auto-Injector for Asthma
October 5th 2019Benralizumab is a monoclonal antibody that binds directly to the IL-5 receptor alpha on eosinophils and attracts natural killer cells to induce rapid depletion of eosinophils via programmed cell death.
Read More